Company: XERI
Filing Date: 2025-10-02
Form Type: 10-K
Source: 0001477932-25-007303
Chunk: 287

Company: XERIANT, INC.
Filing Date: 2025-10-02
Form: 10-K
Item: Item 1C
Chunk 287
---
Net loss  (1,646,898)  (3,103,101)         Less net loss attributable to noncontrolling interest  (17,207)  (32,647)         Net loss attributable to common stockholders $(1,629,691) $(3,070,454)         Net loss per common share - basic and diluted $(0.00) $(0.01)         Weighted average number of common shares outstanding - basic and diluted  620,875,226   443,262,234 

The accompanying notes are an integral part of these consolidated financial statements. 

 F-4Table of Contents

XERIANT, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED JUNE 30, 2025 AND 2024

   Series A Preferred Stock    Series B Preferred Stock    Common Stock   Common stockto be  Additional Paid-In   Accumulated   Non-Controlling     Shares   Amount   Shares   Amount   Shares   Amount   Issued   Capital   Deficit   Interest    Total  Balance June 30, 2023  757,395   8   1,000,000   10   389,433,144   3,894   51,950   19,789,793   (23,638,461 )  (2,827,294 )  (6,620,100 )                                             Stock issued for services  -   -   -   -   17,001,960   170   -   374,736   -   -   374,906                                              Conversion of Series A Preferred to Common Stock  (51,500 )  (1 )  -   -   51,500,000   515   -   (515)  -   -   (1 )                                             Conversion of convertible notes payable and accrued interest into common stock  -   -   -   -   66,918,200   669   -   668,513   -   -